Dr Keith Tsui

Medopad

Keith is the lead for life science partnerships in the clinical product team. In addition, Keith is also responsible for developing the strategy to demonstrate outcome and evidence for remote patient monitoring within Medopad. Prior to Medopad, Keith was a management consultant at Carnall Farrar, a healthcare consulting firm. Keith completed his medical training at The University of Hong Kong and holds a MPhil in Bioscience Enterprise from University of Cambridge.

dont miss

Remote Patient Monitoring: Bringing the Hospital into the Home

Patients with rare and chronic disease spend 95% of their time outside hospital, where clinicians typically have no or intermittent access to patient health data.
Here, we explore how a remote patient monitoring solution can be applied within the care pathway for oncology, to improve visibility of patient progress, impact patient engagement, and improve pathway efficiencies. Oncology monitoring at King’s College Hospital, HCA, and Sussex Cancer Centre will be explored.

EVEN MORE SEMINARS

  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Mr Hamish Clouston: Speaking at the Oncology Convention

    Mr Hamish Clouston
    The Christie NHS Foundation Trust

    Surgical Management of Advanced Colonic and Rectal Malignancies.

  • Dr Natalie Cook: Speaking at the Oncology Convention

    Dr Natalie Cook
    University of Manchester/Christie NHS Foundation Trust

    Early phase trial options in prostate cancer

  • Professor Jayant Vaidya: Speaking at the Oncology Convention

    Professor Jayant Vaidya
    University College London

    Targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer